Literature DB >> 11225995

CD20: a gene in search of a function.

J K Riley1, M X Sliwkowski.   

Abstract

CD20 is a signature B-cell differentiation antigen. The function of CD20 is unknown, although it is thought to be involved in B-cell activation, regulation of B-cell growth, and transmembrane calcium flux. This review covers several topics important for understanding CD20 biology. These topics include the expression pattern and transcriptional regulation of the CD20 gene, the structure of the protein and its interaction with other cell surface molecules, as well as CD20 phosphorylation and putative functions. An understanding of CD20 function from signal transduction to biological implications may prove important for the mechanistic understanding of the treatment of certain types of cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11225995

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  34 in total

Review 1.  Role of CD20 monoclonal antibodies in previously untreated chronic lymphocytic leukemia.

Authors:  Sameer A Parikh; William G Wierda
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2010-06

Review 2.  Update on rituximab.

Authors:  R Eisenberg
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

Review 3.  B-cell inhibitors as therapy for rheumatoid arthritis: an update.

Authors:  Jennifer Kwan-Morley; Daniel Albert
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

4.  Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells.

Authors:  Hui Xu; Mark S Williams; Lisa M Spain
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

Review 5.  Novel and emerging targeted-based cancer therapy agents and methods.

Authors:  Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-02-09

6.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

7.  MS4a4B, a CD20 homologue in T cells, inhibits T cell propagation by modulation of cell cycle.

Authors:  Hui Xu; Yaping Yan; Mark S Williams; Gregory B Carey; Jingxian Yang; Hongmei Li; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

8.  Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies.

Authors:  Gadi Gazit Bornstein; Christophe Quéva; Mohammad Tabrizi; Anne van Abbema; Carlos Chavez; Ping Wang; Orit Foord; Kiran Ahluwalia; Naomi Laing; Sandhya Raja; Shenghua Wen; Larry L Green; Xiaodong Yang; Carl Webster; Ross Stewart; David Blakey
Journal:  Invest New Drugs       Date:  2009-07-21       Impact factor: 3.850

9.  B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.

Authors:  Joseph M Tuscano; Jacob Sands
Journal:  Biologics       Date:  2009-07-13

10.  Rituximab in the treatment of non-Hodgkin's lymphoma.

Authors:  Beate Hauptrock; Georg Hess
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.